Company / Profit Margin
4D Molecular Therapeutics, Inc. Profit Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-434778.4%
FY2025
5-year range
-434778.4% / -395.4%
FY2021-FY2025
Trend
-89252.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -89252% YoY in FY2025, a notable deviation from the 5-year average annual change of -17978%.
Based on SEC 10-K filings.
-434778.4% in FY2025 with a 5-year CAGR of -434072.6%.
Declined from -3435.4% to -434778.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -434383.0pp
- 5-Year Change
- -434072.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 89252.1% year-over-year.
- Peak profit margin was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -434778.4% | -89252.1% |
| FY2024 | -486.6% | +85.8% |
| FY2023 | -3435.4% | -768.9% |
| FY2022 | -395.4% | +5.1% |
| FY2021 | -416.5% | +41.0% |
| FY2020 | -705.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026